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The insertion/deletion (I/D) polymorphism in the angiotensin-converting enzyme gene has 
been reported to be implicated in the predisposition to essential hypertension (EH). This association 
may depend on ethnic and genetic backgrounds. The objective of this study was to determine if the 
possible I/D polymorphism in the Bantu ethnic group of Cameroon is associated with EH. Data 
were analyzed from 60 patients and 50 healthy controls in order to access the risk factors of EH in 
this ethnic group. Comparison of gene and allele frquency distributions between the two 
populations revealed that systolic and diastolic blood pressures, age, family history and lack of 
physical exercise were risk factors of EH in this ethnic group. Comparison of means of age, systolic 
and diastolic blood pressures as well as the proporti ns of individuals with a family history of EH 
and lack of physical exercise were higher in the hypertensive than the normotensive group (p < 
0.05). In addition, Comparison of genotype and allele frequencies between the two populations did 
not reveal statistically significant differences (p > 0.05). Moreover, analyses of relationship between 
ACE I/D gene variants and EH did not reveal any association (p > 0.05). Consistently, the two 
groups also did not present with differences in I ad D allele distribution (p > 0.05).  These results 
suggest that EH is not associated with ACE I/D polymorphism. 
© 2016 International Formulae Group. All rights reserved. 
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Cardiovascular diseases (CVDs) are 
becoming a major health burden in developing 
countries including Cameroon (Kamadjeu et 
al., 2006; Dzudie et al., 2012, Gomina et al., 
2012). Hypertension (HTN) is a major risk 
factor for CVDs including stroke and 
coronary heart disease. It is a multifactorial 
and polygenic disorder in which the 
interaction between several candidate genes 
and environmental factors play a critical role. 
This disease is becoming a worldwide public 
health problem and a leading cause of 
morbidity and mortality especially in 
developing countries, where studies project an 
increase by 60% by the year 2025 (Kearney et 
al., 2005; Hajjar et al., 2006).  
A WHO 2012 report states that up to 
50% of adults in many countries are estimated 
to have high blood pressure that remain 
undiagnosed. Previous surveys in Cameroon 
on HTN reported prevalence varying from 
12% to 22% in those above 25 years (Cooper 
et al., 1997; Kearney et al., 2004; Mbanya et 
al., 1998). Based on the results of a cross-
sectional survey carried out in 2003, this 
prevalence of HTN was 25.6% in male and 
23.1% in female (Kamadjeu et al., 2006). 
Most recent epidemiological study reported 
the prevalences of males and females in 
Cameroonian population were are 50.1% and 
44.6% respectively (Dzudie et al., 2012).  
This disease is known to be associated 
with both genetic and environmental factors.  
Environmental factors such as lack of physical 
exercise, excessive smoking, alcohol 
consumption, overweight and obesity are 
known to the risk factors involving increased 
blood pressure. Although the development of 
EH has been reported to be caused by both 
genetic and non-genetic risk factors (Whelton 
et al., 2002; Garcia et al., 2003), the 
underlying mechanisms are still not well 
understood. Numerous studies have been 
focused on the role of genetic variation of 
genes implicated in the renin-angiotensin 
system (RAS), particularly the angiotensin-
converting enzyme (ACE) gene. ACE 
polymorphism is reported as a possible 
genetic determinant that could influence the 
development of EH. Association studies 
between this polymorphism and EH have been 
conducted in different countries and 
ethnicities. However, the results obtained 
according to different areas of studies are still 
contradictory. In Japan (Higaki et al., 2000) 
and India (Zarouk et al., 2012), DD genotype 
significantly increased risk of developing EH. 
Whereas no effect of the presence of DD 
genotype was observed in  Dutch (Schidmt et 
al., 1993), Tunisian (Kabadou et al., 2013), 
and Indonesian (Rasyid et al., 2012) 
populations. 
Due to the marked inconsistency in 
findings of the association of ACE 
polymorphism and EH in different ethnicities 
and geographical locations, establishment of 
this association in the Cameroonian 
population could reveal new insights on the 
control, prevention and management on the 
disease. Therefore, identification of these EH-
susceptible genes is potentially useful to 
elucidate the complex genetic mechanisms of 
the disease. This would allow for earlier 
screening and diagnosis of high-risk 
individuals, preventing disease progression 
through early lifestyle changes and 
pharmacological treatment (Quenum et al., 
2014) thus contributing to a reduction of 
complications and incidence of EH  
Cameroon is made up of 10 Regions 
with over 240 tribes distributed in three main 
ethnic groups: Bantu (Center, South, East, 
Southwest and Littoral regions), Semi-Bantu 
(North West and West regions) and Fulbes 
(Adamawa, Far North and North regions) 
(Achidi et al., 2012). The present study was 
undertaken to determine the association 
between ACE I/D gene polymorphism and EH 
among the Bantu ethnic population in Buea, 
South West Region of Cameroon.   
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MATERIALS AND METHODS 
Study design 
This was a cross sectional population-
based study with participants randomly 
selected on a home-to-home basis. Ethical 
clearance and administrative authorization 
required for this investigation were obtained 
from the Cameroon Bioethics Initiative-
Ethical Review and Consultancy Committee 
(CAMBIN-ERCC), Yaounde-Cameroon and 
the South West Regional Delegation of Public 
Health respectively. Informed consent was 
obtained from all participants.  
 
Study population 
This study included 60 EH patients 
(hypertensives) and 50 healthy controls 
(normotensives) selected from the population 
attending the Buea Health District area. The 
hypertensive group was comprised of 
unrelated individuals having been previously 
diagnosed with HTN and/or took anti-
hypertensive drugs, having a blood pressure 
≥140/90 mmHg, aged between 22 and 81 
years inclusive.   
Persons who had developed 
complications as a result of HTN, aged less 
than 22 or older than 81,  were excluded from 
the study.  Unrelated subjects and without any 
history of HTN, diabetes and other 
immunosuppressive conditions were enrolled 
as normal control subjects. All participants 
were of the Bantu ethnic origin as well as their 
ancestors three generations back.  
 
Collection of demographic, 
anthropometric, biological and biochemical 
data 
A certified nurse used structured 
questionnaires for collection of both 
demographic data (age, sex, family history, 
alcohol consumption) and anthropometric data 
(height & weight) (Knowles et al., 2007). The 
body mass index (BMI) was calculated 
according to Quetelet equation (Lacksmi et 
al., 2015). For acquisition of biological data 
two morning systolic (SBP) and diastolic 
(DBP) blood pressure measurements were 
taken using a sphygmomanometer (Omron 
health care, Illinois, USA) as described by 
Sharman et al., 2015. A third measurement 
was taken only when the difference between 
the two measurements was greater than 5 
mmHg, and the readings were averaged for 
analysis. A 5-min. relaxation period between 
measurements was maintained for all subjects. 
For biochemical data, fasting blood 
sugar (FBS) was determined in mg/dl glucose 
using OneTouch UltraMini stripTM and 
analyzer (Carlifornia, USA). Serum 
triglycerides (TGs) were determined by 
enzymatic colorimetric method using a 
commercially kit (ChronoLab, Barcelona, 
Spain) according to the manufacturer's 
instructions. Total cholesterol (TC) and high 
density lipoprotein cholesterol (HDL-C) were 
determined using a Kit (ChronoLab, 
Barcelona, Spain) according to the 
manufacturer's instructions. Serum LDL was 
calculated using the formula:  LDL-C = (TC) - 
(HDL-C) - (TG/5) (NIH 2001). 
 
ACE gene I/D polymorphism 
Two millilitres of whole blood were 
collected by venipuncture from patients in 
EDTA-microtainer tubes and kept at 4 oC for 
less than 12 hours until DNA extraction. 
Genomic DNA was extracted from the whole 
blood by non-enzymatic salting out method as 
described by Sajja et al., 2014.  The DNA 
extract was used directly for PCR or stored at-
20° C to be used later for PCR 
PCR amplification of the ACE gene 
was done using  specific primers to ACE gene 
as described by Nakhjavani et al., 2007. The 
reaction was performed in 100 µL PCR tubes 
with 5 µL of 100 µM of each primer (forward: 
5’-CTG GAG ACC ACT CCC ATC CTT 
TCT-3’ and reverse: 5’-GAT GTG GCC ATC 
ACA TTC GTC AGAT-3’) in a final volume 
of 24 µL, containing 1.5 µL genomic DNA 
(0.2 µg) suspension and 12.5 µL of PCR 
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Master Mix (Sigma). All DNA samples were 
quantified by a spectrophotometer (Unico 
SpectroQuest Model SQ2800, USA) as 
described by the manufacturer. PCR was done 
with a pre-denaturation step at 94 oC for 1 
min, then the DNA was amplified for 30 
cycles with a denaturation step at 94 oC for 30 
sec, annealing at 58 oC for 30 sec, and 
extension step at 72 oC for 1 min followed by 
a final extension step at 72 oC for 5 min. PCR 
products were analyzed on 3% agarose gel.  
Mistyping of the ID genotype for DD 
genotype due to preferential amplification of 
the D allele (190 bp) over the I allele (490 bp) 
was verified using a second set of insertion 
allele-specific primers ( primer: 5'-TCG GAC 
CAC AGC GCC CGC CAC TAC-3' and 
antisense primer: 5'- TCG CCA GCC CTC 
CCA TGC CCA TAA-3').  
 
RESULTS 
Clinical data from hypertensive and 
normotensive subjects 
In total, 110 subjects were examined, 50 of 
them being normotensive, and 60 
hypertensive. Anthropometric, biochemical 
and biological data were compared between 
hypertensive and normotensive subjects. 
Comparison of anthropometric data and 
proportions of life style parameters between 
normotensive and hypertensive subjects 
revealed that no significant differences were 
observed except for the lack of exercise and 
family history. The proportion of individuals 
that did not make exercise was significantly 
higher in the hypertensive than that of 
normotensive group (p = 0.011) The same 
results were obtained for family history (p = 
0.018) (Table 1). In the same manner, 
biological and biochemical data comparison 
between the two groups showed that SBP and 
DBP were significantly higher in the 
hypertensive group than the normotensive 
(p=0.0001 in both cases) Analysis of the 
means of the clinical characteristics between 
hypertensive and normotensive group showed 
no statistical significant differences (RBS: p= 
0.2882;  TC: p= 0.9450 ;  TG: p= 0.9761;  
HDL-C: p =0.9999 ;  and LDL-C:  p= 0.8920) 
(Table 2).  
 
Genotype and allele frequencies of ACE I/D 
gene polymorphisms 
To investigate the role of the ACE gene 
in the prediction of EH, genotype and allele 
frequencies were compared between 
normotensive and hypertensive subjects. 
Following genotyping both normotensives and 
hypertensives, deletion polymorphism was 
characterized by a 190-bp fragment, while the 
presence of the insertion was observed as a 
490-bp fragment. Whereas the II genotype 
was totally absent, the ID and DD genotypes 
were present in both study groups (Figure 1). 
Verification for mistyping of the DD genotype 
yielded a 335-bp fragment in the presence of 
the I-allele and no product for homozygote 
DD genotype (Data not shown). 
 
Association studies of ACE gene variants 
with risk factors of hypertension 
An association study was conducted 
between ACE gene variants and risk factors in 
the study populations. Analyses of results 
reveal that no statistically significant 
differences in ACE gene or allele frequencies 
existed between the normotensives and the 
hypertensives. Consistently, similar results 
were obtained when ACE gene and allele 
frequencies were compared between 
hypertensive subjects with high SBP or DBP 
with those of low SBP or DBP (Table 3). 
Similarly, there was neither association of 
ACE gene variants with gender and age group 
(Table 4) nor with life style risk factors of 
hypertension (Table 5). Merging the two 
populations into a single group did not reveal 
any association between genotype and risk 
factors of EH (Data not shown).
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Table 1: Characteristics and statistical comparison of anthropometric data and life style parameters 
between the hypertensive and normotensive subjects. 
 
Parameters Hypertensives (n=60) Normotensives (n=50)           Test Statistics 
Sex (Male/Female) 29/31 28/22 χ2=0.642; p = 0.4230 
Age: Years 51.47±12.66 46.30±10.81 p=0.025;  95% CI 
BMI (Kg/m2) 28.90± 4.922 27.73±4.362 p=0.3724 
Alcohol consumption 46 (76.67%) 44 (88%) χ2=0.125;  p=0.723 
Smoking 6 (10 %) 9 (18%) χ2 =1.482; p=0.223 
Lack of exercise 27 (45%) 38 (76%) χ2 = 6.392; p=0.011* 
Family History 30 (50%) 13 (26%) χ2 = 3.917; p=0.047* 
Analyses of results between normotensives and hypertensives were done for Sex, Alcohol comsumption, Smoking, Lack of 






Table 2: Characteristics and statistical comparison of and biological and biochemical data between 
the hypertensive and normotensive subjects. 
 
Parameters Reference range Hypertensives (n=60) Normotensives (n=50) p value 
SBP  (mm Hg) <140 150.3± 16.77 117.9±11.35 0.0001* 
DBP (mm Hg) <90 97.02±9.092 79.06±7.646 0.0001* 
RBS (mg/dL) <200 137.5±114.9 124.6±34.79 0.2882 
TC (mg/dL) <200 218.0±93.14 217.80±99.50 0.9450 
TG (mg/dL) 35-160 113.9±95.19 110.0±77.96 0.9761 
HDL-C (mg/dL) >65 68.32±25.05 68.32±23.43 0.9999 
LDL-C (mg/dL) <150 115.5± 96.74 120.8±98.78 0.8920 




Table 3: Association of ACE gene variants with biological risk factors of hypertension. 
 
 Genotype Allele 
II ID DD I D 
Status            Hypertensives  n = 60 00 35 25 35 85 
% 00 58.3 41.7 29.2 70.8 
           Normotensives  n = 50 00 33 17 33 67 
% 00 66 34 33 67 
 χ2=0.679; p=0.4099  χ2=0.375; p=0.540  
DBP in hypertensives    >90 mmHg      n=45 00 24 21 24 66 
  ≤90 mmHg       n =15 00 11 4 11 19 
 χ2=1.851;  P=0.173      χ2=1.089; P=0.296         
SBP in Hypertensives     >140 mmHg      n =46 00 27 19 27 65 
   ≤140 mmHg     n= 14 00 8 6 8 20 
 χ2=0.010; P=0.917 χ2=0.006;  P=0.936   
All values were compared using the Chi square test 
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Table 4: Association of ACE gene variants with anthropometric risk factors of hypertension.  
 
             Genotype Allele 
II ID DD I D 
 
Gender 
Males Normotensive n =28 00 16 12 16 40 
Hypertensive n =29 00 12 17 12 46 
 χ2 =1.416; P=0.234  χ2=0.955; P=0.328 
Females Normotensive n =22 00 17 4 17 25 
Hypertensive n =31 00 23 8 23 39 








22-34 Normotensive n =6 00 03 03 03 09 
Hypertensive n =5 00 04 01 04 06 
 χ2=1.061; P=0.303 χ2=0.565; P=0.452 
35-49 Normotensive n =26 00 19 07 19 33 
Hypertensive n =19 00 12 07 12 26 
 χ2=0.504; P=0.477 χ2=0.239; P=0.624 
50-64 Normotensive n =15 00 08 07 08 22 
Hypertensive n =27 00 15 12 15 39 
 χ2=0.019; P=0.887 χ2=0.011; P=0.912 
65-81 Normotensive n =3 00 03 00 03 03 
Hypertensive n =9 00 04 05 04 14 
 χ2=2.857; P=0.09 χ2=I.681; P=0.194 





Table 5: Association of ACE gene variants with family history and lack of exercise. 
 
             Genotype Allele 





Yes Normotensive n = 38 00 25 13 25 51 
Hypertensive n =27 00 15 12 15 39 
 χ2=0.69; P=0.403 χ2=0.388; P=0.533 
 No Normotensive n =12 00 08 04 08 16 
Hypertensive n =33 00 20 13 20 46 





Yes Normotensive n =15 00 10 05 10 20 
Hypertensive n =33 00 18 15 18 48 
 χ2=0.623; P=0.429  χ2=0.366; P=0.544 
No Normotensive n =35 00 23 12 23 47 
Hypertensive n =27 00 10 17 10 44 
 χ2=5.035; P=0.024; χ2=3.209; P=0.073 
Chi square test was used for data analysis. 
 




Figure 1: Typical agarose gel electrophoregram of ACE gene polymorphism. Lanes 1, 2, 4 & 5: ID 
genotype; Lanes 3 & 6: DD genotype; Lane NC: negative control. Arrows indicate the 490 and the 190 bp fragments of the I 




The present study was aimed at 
investigating the association of ACE I/D 
polymorphism with EH among the Bantu 
ethnic population in Buea, SWR of 
Cameroon. The identification of this 
polymorphism in this subset of the 
Cameroonian population as a health risk 
factor will help people predisposed to EH to 
take adequate health decisions in order to 
prevent the disease and its complications. 
A subpopulation analysis according to 
potential risk factors of EH revealed that age 
SBP, DBP, lack of exercise and family history 
were risk factors in the Bantu ethnic group 
while gender, BMI, lipid profile, alcoholism 
and smoking were not (Tables 1 & 2). EH was 
more prevalent in the elderly than young 
people. This was in accordance with previous 
studies in different towns of Cameroon 
(Kamadjeu et al., 2006; Dzudie et al., 2012). 
Increase in age is thought to increase blood 
pressure because as the arteries become 
hardened, there is increased resistance to 
blood flow (Roger et al., 2011).  
The high SBP and DBP in hypertensive 
patients were naturally expected. These results 
reveal that SBP and DBP are risk factors for 
EH in the Bantu ethnic population of SWR 
Cameroon. In recent years, considerable 
evidence has suggested that changes in 
vascular endothelial function may cause the 
increase in vascular tone, in addition to 
sympathetic activity and increased circulating 
levels of angiotensin II (Franklin et al., 2011). 
The proportion of individuals who did 
not make exercise or with a family history of 
EH was statistically different between the 
hypertensive patients and control population, 
suggesting that genetic and lifestyle 
environmental factors do influence the ability 
to develop this disease in the Bantu ethnic 
group. These observations are in line with 
earlier reports (Bhavani et al., 2004), thereby 
providing evidence that heritable factors in 
combination with a number of recognized 
environmental risk factors are important 
determinants of the pathogenesis of EH in this 
study population.  
Analysis of association of identified 
risk factors of hypertension with ACE 
genotypes did not reveal any differences in 
genotype and allele prevalence between the 
hypertensive and normotensive populations 
(Figures 3, 4 and 5). These data suggests that 
there is no association between the ACE I/D 
polymorphism and EH. Consistently, merging 
the two groups of normotensives and 
hypertensives into a single population did not 
reveal any association between ACE gene 
variants and risk factors of EH (Data not 
shown). Similar results have been reported in 
the Dutch (Schidmt et al., 1993), Tunisian 
(Kabadou et al., 2013), and Indonesian 
(Rasyid et al., 2012) populations and has been 
attributed to ethnic background.  
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The present study clearly demonstrates 
that the ACE I/D gene variants do not 
predispose Cameroonians of the Bantu ethnic 
group to EH.  
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